3billion is participating in the K-gNBS program as a test provider conducting WGS, interpretation, and result reporting.
Published
Signal category
Partnerships
Quote
ā3billion is participating in the K-gNBS program as a test provider conducting WGS, interpretation, and result reporting.ā
ā Changwon Keum|3billion team
Company
3billion
Your One Answer Genetic testing for rare diseases made more efficient and more accessible
- Industry
- Biotechnology Research
- Location
- Gangnam-gu, KR
- Company size
- 72 employees
šš»š±š¶š»š“ ššµš² šš¶š®š“š»š¼ššš¶š° š¢š±šššš²š šš¶ššµ šš-š½š¼šš²šæš²š± šš²š»š¼šŗš¶š°š. 3billion is dedicated to making rare disease diagnosis faster, more accurate, and accessible for patients everywhere. We provide AI-driven genetic testing covering all rare diseases, helping physicians deliver answers with confidence. Through our unique daily reanalysis system, patients continue to receive new diagnoses without additional cost. 80,000+ patients in 80+ countries have already been tested, in collaboration with 800+ medical institutions worldwide. In 2024, 3billion was listed on KOSDAQ, a recognition of our leading technology and global growth. Our mission is simple yet powerful: to ensure that every rare disease patient has a chance to receive an answer. š Visit us: https://3billion.io š© For inquiries: support@3billion.io
Founded 2016